Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples